David J Matlin insider trades

Open-market stock purchases and sales by David J Matlin, Director at Clene Inc, from SEC Form 4 filings since Jan 27, 2010.

Track record: 88% of 24 scored buys are up 5% or more since purchase, averaging +60%.

Recent trades

DateStockTradeValue
May 21, 2026CLNN Clene IncBought (not open market)—
May 21, 2026CLNN Clene IncBought (not open market)—
May 14, 2026TLSI TriSalus Life Sciences, IncBought (not open market)—
May 14, 2026TLSI TriSalus Life Sciences, IncBought (not open market)—
May 14, 2026TLSI TriSalus Life Sciences, IncBought (not open market)—
Feb 19, 2026CLNN Clene IncBought (not open market)—
Jan 13, 2026CLNN Clene IncBought$217K
Jan 13, 2026CLNN Clene IncBought (not open market)$240K
Jan 13, 2026CLNN Clene IncBought (not open market)$560K
Nov 13, 2025CLNN Clene IncBought (not open market)—

Companies traded

  • CLNN Clene Inc: 29 buys, last May 21, 2026
  • TLSI TriSalus Life Sciences, Inc: other filings, last May 14, 2026
  • USWS U.S. Well Services, Inc: 3 buys, 1 sale, last Mar 2, 2022
  • LONE Lonestar Resources US Inc: other filings, last Oct 5, 2021
  • (NYSE:FBC) Flagstar Bancorp Inc: other filings, last Jan 20, 2021
  • MTACU MedTech Acquisition Corp: other filings, last Dec 22, 2020
  • FBC Flagstar Bancorp Inc: 4 buys, 6 sales, last Nov 10, 2020
  • MYOS Myos Rens Technology Inc: 1 buy, last Mar 6, 2020
  • CAA CalAtlantic Group, Inc: 1 sale, last Jun 14, 2017
  • SPF Standard Pacific Corp /de/: 1 buy, 1 sale, last May 20, 2013

Get free alerts when David J Matlin files a new trade →